Drug Administration
Untracked preview. This is not a tracked Signal Bureau entity — the page is generated on request from live coverage search, is not indexed, and carries no editorial curation. Tracked entities live on the Wire.
If Drug Administration is on your watch list: what changed in the coverage, what the reporting asserts, and what the crowd is pricing.
What’s changed
- Formal Meetings Between the Food and Drug Administration and Sponsors or Requestors of Over-the-Counter Monograph Drugs · FDA Drug News · 2026-07-13
- ZUBB Dietary Supplement may be harmful due to hidden ingredient · FDA Drug News · 2026-09-05
- Temporary Policies for Compounding Certain Starter Parenteral Nutrition Drug Products for Neonates · FDA — What's New: Drugs · 2026-09-05
- FDA grants accelerated approval to camizestrant with a CDK4/6 inhibitor for ESR1-Mutated HR-positive, HER2-negative locally advanced or metastatic breast cancer · FDA — What's New: Drugs · 2026-09-05
- FDA Takes Steps to Maintain Newborn Access to Life-Saving Starter Nutrition Products · FDA — Press Releases · 2026-09-05
- FDA Grants Accelerated Approval to a New Breast Cancer Treatment · FDA — Press Releases · 2026-09-05
What the reporting says
Across 252 tracked stories from 35 outlets, reporting on Drug Administration most often describes regulatory approvals (133), launches or releases (3), elections (1), meetings or visits (1), treaties or agreements (1), public statements (1).
It shows up alongside FDA (251), U S Food (120), Drug Evaluation (22), Cder (14), Federal Food (14), Cosmetic Act (13), United States (24), US Food (19).
Two steps out: AI (through FDA, 41 shared stories on the weaker link); Colorectal Cancer (through FDA, 37 shared stories on the weaker link); Drug Development (through FDA, 37 shared stories on the weaker link); Immunotherapy (through FDA, 34 shared stories on the weaker link).
Tracked since Apr 6, with coverage on 74 separate days — concentrated in Pharma Regulatory and Biotech Pharma.